Paul C. Grimm

Publications

• A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety. Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschênes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P. Clin J Am Soc Nephrol. 2012; 7 (7): 1112-20
• Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients. Nguyen L, McClellan RB, Chaudhuri A, Alexander SR, Chen SF, Concepcion W, Grimm P. Transplantation. 2012; 94 (5): 450-5
• Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type. Chaudhuri A, Kambham N, Sutherland S, Grimm P, Alexander S, Concepcion W, Sarwal M, Wong C. Pediatr Transplant. 2012; 16 (5): E183-7
• Steroid-free immunosuppression in teenagers: living without a safety net. Grimm PC, Concepcion W. Pediatr Transplant. 2012; 16 (4): 305-7
• Morphometric and visual evaluation of fibrosis in renal biopsies. Farris AB, Adams CD, Brousaides N, Della Pelle PA, Collins AB, Moradi E, Smith RN, Grimm PC, Colvin RB. J Am Soc Nephrol. 2011; 22 (1): 176-86
• Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation. Jungraithmayr TC, Hofer K, Cochat P, Chernin G, Cortina G, Fargue S, Grimm P, Knueppel T, Kowarsch A, Neuhaus T, Pagel P, Pfeiffer KP, Schäfer F, Schönermarck U, Seeman T, Toenshoff B, Weber S, Winn MP, Zschocke J, Zimmerhackl LB. J Am Soc Nephrol. 2011; 22 (3): 579-85
• Steroid avoidance in renal transplantation. Lightner A, Concepcion W, Grimm P. Curr Opin Organ Transplant. 2011; 16 (5): 477-82
• Melamine nephrotoxicity: an emerging epidemic in an era of globalization. Bhalla V, Grimm PC, Chertow GM, Pao AC. Kidney Int. 2009; 75 (8): 774-9
• Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits. Li L, Chang A, Naesens M, Kambham N, Waskerwitz J, Martin J, Wong C, Alexander S, Grimm P, Concepcion W, Salvatierra O, Sarwal MM. Am J Transplant. 2009; 9 (6): 1362-72
• Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ. Am J Transplant. 2007; 7 (3): 518-26
• Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy. Schachter AD, Benfield MR, Wyatt RJ, Grimm PC, Fennell RS, Herrin JT, Lirenman DS, McDonald RA, Munoz-Arizpe R, Harmon WE. Pediatr Transplant. 2006; 10 (8): 914-9
• Use of an immune function assay to monitor immunosuppression. Grimm P, Pediatr Transplant. 2006; 10 (5): 533-5
• Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury. Zaman A, Cui Z, Foley JP, Zhao H, Grimm PC, Delisser HM, Savani RC. Am J Respir Cell Mol Biol. 2005; 33 (5): 447-54
• Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profiling. Melk A, Mansfield ES, Hsieh SC, Hernandez-Boussard T, Grimm P, Rayner DC, Halloran PF, Sarwal MM. Kidney Int. 2005; 68 (6): 2667-79
• Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis. Sund S, Grimm P, Reisaeter AV, Hovig T. Nephrol Dial Transplant. 2004; 19 (11): 2838-45
• Dietary phosphorus reduction by pretreatment of human breast milk with sevelamer. Ferrara E, Lemire J, Reznik VM, Grimm PC. Pediatr Nephrol. 2004; 19 (7): 775-9
• Mycobacterial peritonitis in pediatric peritoneal dialysis patients. Ferrara E, Lemire J, Grimm PC, Reznik VM, Mendoza SA, Leake JA, Benador NM. Pediatr Nephrol. 2004; 19 (1): 114-7
• Novel methods of prediction of long-term renal allograft outcome. Grimm PC, Pediatr Transplant. 2004; 8 (6): 531-2
• The protocol renal allograft biopsy: has its time come? Grimm P, Pediatr Transplant. 2004; 8 (1): 3-5
• Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. Melk A, Kittikowit W, Sandhu I, Halloran KM, Grimm P, Schmidt BM, Halloran PF. Kidney Int. 2003; 63 (6): 2134-43
• Computer-assisted quantification of fibrosis in chronic allograft nephropaty by picosirius red-staining: a new tool for predicting long-term graft function. Pape L, Henne T, Offner G, Strehlau J, Ehrich JH, Mengel M, Grimm PC. Transplantation. 2003; 76 (6): 955-8
• Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. Grimm PC, Nickerson P, Gough J, McKenna R, Stern E, Jeffery J, Rush DN. J Am Soc Nephrol. 2003; 14 (6): 1662-8
• Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. Grimm PC, Nickerson P, Jeffery J, Savani RC, Gough J, McKenna RM, Stern E, Rush DN. N Engl J Med. 2001; 345 (2): 93-7
• Neoral pharmacokinetics in Latino and Caucasian pediatric renal transplant recipients. Lemire J, Capparelli EV, Benador N, Grimm P, Macdonald D, Reznik V. Pediatr Nephrol. 2001; 16 (4): 311-4
• Transjugular intrahepatic portosystemic shunt prior to renal transplantation in a child with autosomal-recessive polycystic kidney disease and portal hypertension: A case report. Benador N, Grimm P, Lavine J, Rosenthal P, Reznik V, Lemire J. Pediatr Transplant. 2001; 5 (3): 210-4
• A role for hyaluronan in macrophage accumulation and collagen deposition after bleomycin-induced lung injury. Savani RC, Hou G, Liu P, Wang C, Simons E, Grimm PC, Stern R, Greenberg AH, DeLisser HM, Khalil N. Am J Respir Cell Mol Biol. 2000; 23 (4): 475-84
• Interstitial nephritis in children with Crohn's disease. Benador N, Grimm P, Lemire J, Griswold W, Billman G, Reznik V. Clin Pediatr (Phila). 2000; 39 (4): 253-4
• Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. Grimm PC, McKenna R, Nickerson P, Russell ME, Gough J, Gospodarek E, Liu B, Jeffery J, Rush DN. J Am Soc Nephrol. 1999; 10 (7): 1582-9
• Effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection: a pilot study. Nickerson P, Jeffery J, Gough J, Grimm P, McKenna R, Birk P, Rush D. J Am Soc Nephrol. 1999; 10 (8): 1801-5
• Quantitation of allograft fibrosis and chronic allograft nephropathy. Grimm PC, Nickerson P, Gough J, McKenna R, Jeffery J, Birk P, Rush DN. Pediatr Transplant. 1999; 3 (4): 257-70
• Beneficial effects of treatment of early subclinical rejection: a randomized study. Rush D, Nickerson P, Gough J, McKenna R, Grimm P, Cheang M, Trpkov K, Solez K, Jeffery J. J Am Soc Nephrol. 1998; 9 (11): 2129-34
• Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. Nickerson P, Jeffery J, Gough J, McKenna R, Grimm P, Cheang M, Rush D. J Am Soc Nephrol. 1998; 9 (3): 482-7
• Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection. Lipman ML, Shen Y, Jeffery JR, Gough J, McKenna RM, Grimm PC, Rush DN. Transplantation. 1998; 66 (12): 1673-81
• Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function. McKenna RM, Lee KR, Gough JC, Jeffery JR, Grimm PC, Rush DN, Nickerson P. Transplantation. 1998; 66 (1): 38-43
• Nonradioactive Northern blotting with biotinylated and digoxigenin-labeled RNA probes. Meltzer JC, Sanders V, Grimm PC, Chiasson N, Hoeltke HJ, Garrett KL, Greenberg AH, Nance DM. Electrophoresis. 1998; 19 (8-9): 1351-5
• Pediatric renal transplantation: indications and special considerations. A position paper from the Pediatric Committee of the American Society of Transplant Physicians. Davis ID, Bunchman TE, Grimm PC, Benfield MR, Briscoe DM, Harmon WE, Alexander SR, Avner ED. Pediatr Transplant. 1998; 2 (2): 117-29
• Production of digoxigenin-labelled RNA probes and the detection of cytokine mRNA in rat spleen and brain by in situ hybridization. Meltzer JC, Sanders V, Grimm PC, Stern E, Rivier C, Lee S, Rennie SL, Gietz RD, Hole AK, Watson PH, Greenberg AH, Nance DM. Brain Res Brain Res Protoc. 1998; 2 (4): 339-51
• Protocol biopsies in renal transplantation: research tool or clinically useful? Rush DN, Nickerson P, Jeffery JR, McKenna RM, Grimm PC, Gough J. Curr Opin Nephrol Hypertens. 1998; 7 (6): 691-4
• Enhanced immunohistochemical detection of autonomic nerve fibers, cytokines and inducible nitric oxide synthase by light and fluorescent microscopy in rat spleen. Meltzer JC, Grimm PC, Greenberg AH, Nance DM. J Histochem Cytochem. 1997; 45 (4): 599-610
• The receptor for hyaluronan-mediated motility is expressed in human renal allografts and is correlated with Banff chronic rejection scores. Routledge MW, Rush D, McKenna R, Gough J, Jeffery J, Stem E, Liu B, Savani RC, Grimm PC. Transplant Proc. 1997; 29 (6): 2603-4
• Histamine H1-receptors in the nasal mucosa: a mystery solved? Simons FE, Grimm PG. Clin Exp Allergy. 1996; 26 (4): 368-70
• Low frequency of infiltrating cells intensely expressing T cell cytokine mRNA in human renal allograft rejection. Grimm PC, McKenna RM, Gospodarek EM, Jeffery JR, Rush DN. Transplantation. 1995; 59 (4): 579-84
• Hemolytic uremic syndrome: the most common cause of acute renal failure in childhood. Grimm PC, Ogborn MR. Pediatr Ann. 1994; 23 (9): 505-11
• Rapid nonradioactive in situ hybridization for interleukin-2 mRNA with riboprobes generated using the polymerase chain reaction. Birk PE, Grimm PC. J Immunol Methods. 1994; 167 (1-2): 83-9
• Renal tubule Na,K-ATPase polarity in glucocorticoid-induced polycystic kidney disease. Ogborn MR, Sareen S, Grimm PC. J Histochem Cytochem. 1993; 41 (4): 555-8
• Pediatric renal biopsy in the ambulatory care environment. Ogborn MR, Grimm PC. Pediatr Nephrol. 1992; 6 (3): 311-2
• Pediatric renal transplantation. Grimm PC, Ettenger R. Adv Pediatr. 1992: 39 441-93
• High cellular anti-HLA immune responsiveness accompanies the highly sensitized (high PRA) state in dialysis patients. Grimm PC, Ettenger RB. Transplant Proc. 1991; 23 (1 Pt 1): 405-6
• Long-term results with cyclosporine immune suppression in pediatric cadaver renal transplantation. Ettenger RB, Rosenthal JT, Marik J, Grimm PC, Nelson P, Malekzadeh MH, Fine RN. Transplant Proc. 1991; 23 (1 Pt 2): 1011-2
• Recombinant human erythropoietin decreases anti-HLA sensitization and may improve renal allograft outcome: involvement of anti-idiotypic antibody. Grimm PC, Sekiya NM, Robertson LS, Robinson BJ, Ettenger RB. Transplant Proc. 1991; 23 (1 Pt 1): 407-8
• Renal transplantation in children. Yadin O, Grimm PC, Ettenger RB. Pediatr Ann. 1991; 20 (12): 657-67
• Sensitized B lymphocytes contribute to acute allograft rejection. Gritsch HA, Grimm PC, Ettenger RB, Rosenthal JT. J Surg Res. 1991; 51 (3): 204-9
• The impact of recombinant human erythropoietin therapy on renal transplantation. Ettenger RB, Marik J, Grimm P. Am J Kidney Dis. 1991; 18 (4 Suppl 1): 57-61
• Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity. Grimm PC, Sinai-Trieman L, Sekiya NM, Robertson LS, Robinson BJ, Fine RN, Ettenger RB. Kidney Int. 1990; 38 (1): 12-8
• The microanatomy of the intrahepatic bile duct in polycystic disease: comparison of the cpk mouse and human. Grimm PC, Crocker JF, Malatjalian DA, Ogborn MR. J Exp Pathol (Oxford). 1990; 71 (1): 119-31
• Interstitial nephritis induced by cloxacillin. Grimm PC, Ogborn MR, Larson AJ, Crocker JF. Nephron. 1989; 51 (2): 285-6
• Nifedipine, verapamil and cyclosporin A pharmacokinetics in children. Ogborn MR, Crocker JF, Grimm PC. Pediatr Nephrol. 1989; 3 (3): 314-6